Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake Disorder

Purpose: To quantify the burden of disease in blind patients with Non-24-H Sleep- Wake Disorder (N24HSWD), utilizing longitudinal sleep diary data. N24HSWD is a circadian disorder characterized by a cyclical pattern of aberrant circadian and sleep-wake cycles that are associated with increased frequ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in neurology 2021-01, Vol.11, p.605240-605240, Article 605240
Hauptverfasser: Van Draanen, Lauren, Xiao, Changfu, Polymeropoulos, Mihael H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 605240
container_issue
container_start_page 605240
container_title Frontiers in neurology
container_volume 11
creator Van Draanen, Lauren
Xiao, Changfu
Polymeropoulos, Mihael H.
description Purpose: To quantify the burden of disease in blind patients with Non-24-H Sleep- Wake Disorder (N24HSWD), utilizing longitudinal sleep diary data. N24HSWD is a circadian disorder characterized by a cyclical pattern of aberrant circadian and sleep-wake cycles that are associated with increased frequency of sleep episodes during the school/work day hours. Daytime sleep episodes would be predicted to decrease the opportunity for school/work participation, significantly impacting the quality of life of the patient. Methods: We used the sleep diary data of daytime sleep from a period of similar to 90 days in blind individuals that presented with a sleep complaint. These subjects were identified from a group of blind individuals with N24HSWD (n = 121) and a control group of blind individuals without N24HSWD (n = 57). Results: N24HSWD patients had more frequent and longer episodes of daytime sleep as compared to a control group. Using duration of daytime sleep as a surrogate for defining a healthy or unhealthy day, N24HSWD patients also had significantly fewer healthy days, defined by daytime sleep free days (DSFD), days without a sleep episode between 9:00 a.m. and 5:00 p.m, as compared to the control group. Conclusion: Daytime sleep free day (DSFD) is a useful and specific measure of disease burden in patients with N24HSWD and it is predicted to be correlated with the standardized HRQOL-4, Healthy Days measurement.
doi_str_mv 10.3389/fneur.2020.605240
format Article
fullrecord <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_webofscience_primary_000614400600001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8d866c3861564611a76b266403cce8ae</doaj_id><sourcerecordid>2487432636</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-7e921088b79029a5c7d2407a319a425d77bf3d2df89d7aa8e66e87a7c0417a1a3</originalsourceid><addsrcrecordid>eNqNUk1v1DAUjBCIVkt_ABeUIxLK4q_444JUlpauVMEBUMXJ8tovW5esvdhJEf--TlNW7Q0fbOt5Zuznmap6jdGSUqnedwHGtCSIoCVHLWHoWXWMOWcNIap9_mh_VJ3kfIPKoEpRTl9WR5S2LVZcHFc_z_Lgd2bwYVt_HJODUMeu_uQzmAz16S5O9d4HV6-D87fejabP9ZUfrusvMTSENRdxTPW3HmDfXJlfMHFj0UmvqhddwcLJw7qofpyffV9dNJdfP69Xp5eNZVgMjQBFMJJyIxQiyrRWuNKLMBQrw0jrhNh01BHXSeWEMRI4BymMsKjQDTZ0Ua1nXRfNjd6n0k36q6Px-r4Q01abNHjbg5ZOcm6p5LjljGNsBN-Q8k2IWgvSQNH6MGvtx80OnIUwJNM_EX16Evy13sZbLWSrGGNF4O2DQIq_R8iD3vlsoe9NgDhmTZgUjBJebFhUeIbaFHNO0B2uwUhPDut7h_XksJ4dLpw3j993YPzzswDezYA_sIldth6ChQOsRIBjxso8pQEXtPx_9MoPJSYxrOIYBnoHBNzB_Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2487432636</pqid></control><display><type>article</type><title>Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake Disorder</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Web of Science - Science Citation Index Expanded - 2021&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>PubMed Central</source><creator>Van Draanen, Lauren ; Xiao, Changfu ; Polymeropoulos, Mihael H.</creator><creatorcontrib>Van Draanen, Lauren ; Xiao, Changfu ; Polymeropoulos, Mihael H.</creatorcontrib><description>Purpose: To quantify the burden of disease in blind patients with Non-24-H Sleep- Wake Disorder (N24HSWD), utilizing longitudinal sleep diary data. N24HSWD is a circadian disorder characterized by a cyclical pattern of aberrant circadian and sleep-wake cycles that are associated with increased frequency of sleep episodes during the school/work day hours. Daytime sleep episodes would be predicted to decrease the opportunity for school/work participation, significantly impacting the quality of life of the patient. Methods: We used the sleep diary data of daytime sleep from a period of similar to 90 days in blind individuals that presented with a sleep complaint. These subjects were identified from a group of blind individuals with N24HSWD (n = 121) and a control group of blind individuals without N24HSWD (n = 57). Results: N24HSWD patients had more frequent and longer episodes of daytime sleep as compared to a control group. Using duration of daytime sleep as a surrogate for defining a healthy or unhealthy day, N24HSWD patients also had significantly fewer healthy days, defined by daytime sleep free days (DSFD), days without a sleep episode between 9:00 a.m. and 5:00 p.m, as compared to the control group. Conclusion: Daytime sleep free day (DSFD) is a useful and specific measure of disease burden in patients with N24HSWD and it is predicted to be correlated with the standardized HRQOL-4, Healthy Days measurement.</description><identifier>ISSN: 1664-2295</identifier><identifier>EISSN: 1664-2295</identifier><identifier>DOI: 10.3389/fneur.2020.605240</identifier><identifier>PMID: 33551967</identifier><language>eng</language><publisher>LAUSANNE: Frontiers Media Sa</publisher><subject>blind &amp; visually impaired people ; burden of disease (BOD) ; Clinical Neurology ; HRQOL–health-related quality of life ; Life Sciences &amp; Biomedicine ; Neurology ; Neurosciences ; Neurosciences &amp; Neurology ; non-24 ; non-24 hour sleep-wake disorder ; quality of life ; Science &amp; Technology</subject><ispartof>Frontiers in neurology, 2021-01, Vol.11, p.605240-605240, Article 605240</ispartof><rights>Copyright © 2021 Van Draanen, Xiao and Polymeropoulos.</rights><rights>Copyright © 2021 Van Draanen, Xiao and Polymeropoulos. 2021 Van Draanen, Xiao and Polymeropoulos</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>1</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000614400600001</woscitedreferencesoriginalsourcerecordid><cites>FETCH-LOGICAL-c417t-7e921088b79029a5c7d2407a319a425d77bf3d2df89d7aa8e66e87a7c0417a1a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859444/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859444/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27929,27930,39263,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33551967$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Draanen, Lauren</creatorcontrib><creatorcontrib>Xiao, Changfu</creatorcontrib><creatorcontrib>Polymeropoulos, Mihael H.</creatorcontrib><title>Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake Disorder</title><title>Frontiers in neurology</title><addtitle>FRONT NEUROL</addtitle><addtitle>Front Neurol</addtitle><description>Purpose: To quantify the burden of disease in blind patients with Non-24-H Sleep- Wake Disorder (N24HSWD), utilizing longitudinal sleep diary data. N24HSWD is a circadian disorder characterized by a cyclical pattern of aberrant circadian and sleep-wake cycles that are associated with increased frequency of sleep episodes during the school/work day hours. Daytime sleep episodes would be predicted to decrease the opportunity for school/work participation, significantly impacting the quality of life of the patient. Methods: We used the sleep diary data of daytime sleep from a period of similar to 90 days in blind individuals that presented with a sleep complaint. These subjects were identified from a group of blind individuals with N24HSWD (n = 121) and a control group of blind individuals without N24HSWD (n = 57). Results: N24HSWD patients had more frequent and longer episodes of daytime sleep as compared to a control group. Using duration of daytime sleep as a surrogate for defining a healthy or unhealthy day, N24HSWD patients also had significantly fewer healthy days, defined by daytime sleep free days (DSFD), days without a sleep episode between 9:00 a.m. and 5:00 p.m, as compared to the control group. Conclusion: Daytime sleep free day (DSFD) is a useful and specific measure of disease burden in patients with N24HSWD and it is predicted to be correlated with the standardized HRQOL-4, Healthy Days measurement.</description><subject>blind &amp; visually impaired people</subject><subject>burden of disease (BOD)</subject><subject>Clinical Neurology</subject><subject>HRQOL–health-related quality of life</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Neurosciences &amp; Neurology</subject><subject>non-24</subject><subject>non-24 hour sleep-wake disorder</subject><subject>quality of life</subject><subject>Science &amp; Technology</subject><issn>1664-2295</issn><issn>1664-2295</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>DOA</sourceid><recordid>eNqNUk1v1DAUjBCIVkt_ABeUIxLK4q_444JUlpauVMEBUMXJ8tovW5esvdhJEf--TlNW7Q0fbOt5Zuznmap6jdGSUqnedwHGtCSIoCVHLWHoWXWMOWcNIap9_mh_VJ3kfIPKoEpRTl9WR5S2LVZcHFc_z_Lgd2bwYVt_HJODUMeu_uQzmAz16S5O9d4HV6-D87fejabP9ZUfrusvMTSENRdxTPW3HmDfXJlfMHFj0UmvqhddwcLJw7qofpyffV9dNJdfP69Xp5eNZVgMjQBFMJJyIxQiyrRWuNKLMBQrw0jrhNh01BHXSeWEMRI4BymMsKjQDTZ0Ua1nXRfNjd6n0k36q6Px-r4Q01abNHjbg5ZOcm6p5LjljGNsBN-Q8k2IWgvSQNH6MGvtx80OnIUwJNM_EX16Evy13sZbLWSrGGNF4O2DQIq_R8iD3vlsoe9NgDhmTZgUjBJebFhUeIbaFHNO0B2uwUhPDut7h_XksJ4dLpw3j993YPzzswDezYA_sIldth6ChQOsRIBjxso8pQEXtPx_9MoPJSYxrOIYBnoHBNzB_Q</recordid><startdate>20210121</startdate><enddate>20210121</enddate><creator>Van Draanen, Lauren</creator><creator>Xiao, Changfu</creator><creator>Polymeropoulos, Mihael H.</creator><general>Frontiers Media Sa</general><general>Frontiers Media S.A</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210121</creationdate><title>Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake Disorder</title><author>Van Draanen, Lauren ; Xiao, Changfu ; Polymeropoulos, Mihael H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-7e921088b79029a5c7d2407a319a425d77bf3d2df89d7aa8e66e87a7c0417a1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>blind &amp; visually impaired people</topic><topic>burden of disease (BOD)</topic><topic>Clinical Neurology</topic><topic>HRQOL–health-related quality of life</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Neurosciences &amp; Neurology</topic><topic>non-24</topic><topic>non-24 hour sleep-wake disorder</topic><topic>quality of life</topic><topic>Science &amp; Technology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Draanen, Lauren</creatorcontrib><creatorcontrib>Xiao, Changfu</creatorcontrib><creatorcontrib>Polymeropoulos, Mihael H.</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Draanen, Lauren</au><au>Xiao, Changfu</au><au>Polymeropoulos, Mihael H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake Disorder</atitle><jtitle>Frontiers in neurology</jtitle><stitle>FRONT NEUROL</stitle><addtitle>Front Neurol</addtitle><date>2021-01-21</date><risdate>2021</risdate><volume>11</volume><spage>605240</spage><epage>605240</epage><pages>605240-605240</pages><artnum>605240</artnum><issn>1664-2295</issn><eissn>1664-2295</eissn><abstract>Purpose: To quantify the burden of disease in blind patients with Non-24-H Sleep- Wake Disorder (N24HSWD), utilizing longitudinal sleep diary data. N24HSWD is a circadian disorder characterized by a cyclical pattern of aberrant circadian and sleep-wake cycles that are associated with increased frequency of sleep episodes during the school/work day hours. Daytime sleep episodes would be predicted to decrease the opportunity for school/work participation, significantly impacting the quality of life of the patient. Methods: We used the sleep diary data of daytime sleep from a period of similar to 90 days in blind individuals that presented with a sleep complaint. These subjects were identified from a group of blind individuals with N24HSWD (n = 121) and a control group of blind individuals without N24HSWD (n = 57). Results: N24HSWD patients had more frequent and longer episodes of daytime sleep as compared to a control group. Using duration of daytime sleep as a surrogate for defining a healthy or unhealthy day, N24HSWD patients also had significantly fewer healthy days, defined by daytime sleep free days (DSFD), days without a sleep episode between 9:00 a.m. and 5:00 p.m, as compared to the control group. Conclusion: Daytime sleep free day (DSFD) is a useful and specific measure of disease burden in patients with N24HSWD and it is predicted to be correlated with the standardized HRQOL-4, Healthy Days measurement.</abstract><cop>LAUSANNE</cop><pub>Frontiers Media Sa</pub><pmid>33551967</pmid><doi>10.3389/fneur.2020.605240</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-2295
ispartof Frontiers in neurology, 2021-01, Vol.11, p.605240-605240, Article 605240
issn 1664-2295
1664-2295
language eng
recordid cdi_webofscience_primary_000614400600001
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; PubMed Central
subjects blind & visually impaired people
burden of disease (BOD)
Clinical Neurology
HRQOL–health-related quality of life
Life Sciences & Biomedicine
Neurology
Neurosciences
Neurosciences & Neurology
non-24
non-24 hour sleep-wake disorder
quality of life
Science & Technology
title Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake Disorder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T20%3A14%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estimating%20Burden%20of%20Disease%20Among%20Blind%20Individuals%20With%20Non-24-Hour%20Sleep-Wake%20Disorder&rft.jtitle=Frontiers%20in%20neurology&rft.au=Van%20Draanen,%20Lauren&rft.date=2021-01-21&rft.volume=11&rft.spage=605240&rft.epage=605240&rft.pages=605240-605240&rft.artnum=605240&rft.issn=1664-2295&rft.eissn=1664-2295&rft_id=info:doi/10.3389/fneur.2020.605240&rft_dat=%3Cproquest_webof%3E2487432636%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2487432636&rft_id=info:pmid/33551967&rft_doaj_id=oai_doaj_org_article_8d866c3861564611a76b266403cce8ae&rfr_iscdi=true